Further pointing to the potential merit of GARP as a diagnostic and therapeutic target is the dual impact of GARP on cancer progression—via the modulation of regulatory T cells and through the direct activities of GARP exerted on cancer (stem) cells themselves. This evidence concerns the gene LRRC32 and cancer.